They ought to be going after drug manufacturers directly and forcing them to publish 100% of their research on every new drug they create. They should also incentivize finding off-label uses for existing cheap generic drugs, and disincentivize repackaging technically-distinct versions of old drugs as soon as the generics pop up. There is a lot of room for improvement in this whole sector, and this isn't where it is.